Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Not applicable Interventional

Development of a Virtual Health Care Platform in Heart Failure Patients Transitioning From Hospital to Home

ClinicalTrials.gov ID: NCT07943663

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07943663. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 7:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Feasibility and Performance Evaluation of nucleusRx Virtual Care Platform for Care Management of At-home Heart Failure Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Study will be performed with fifteen (15) Heart Failure (HF) patients for remote monitoring of health and medication adherence following hospital discharges. Participants will be enrolled into two groups: Group 1 (chronic) will be enrolled on Day 30 to 180 post hospital discharge and monitored for 30 days; Group 2 (Acute) will be enrolled on Day 1-3 of hospital discharge after recent HF episodes and monitored for 30 days. Each participant will receive a Pill Dispenser being developed by the study sponsor, a BP machine, a weighing scale and a smartphone loaded with the software developed by the study sponsor that can collect and summarize participant's health data for study physician's/nurse's evaluation. Both BP machine and weighing scale record participant's data automatically to send to the study team physician/nurse for evaluation of his/her health. Outpatient pharmacy will deliver 30 days (+7) of medications as prescribed by the patient's physician in the standard pharmacy vials, and the patients will procure them from their chosen pharmacy outlet. Prescription details for medications will also be sent to the participant's mobile phone. Medications will be uploaded in the dispenser on Day 1 by the patient in presence of a visiting nurse (a member of the study team) who will review and explain medication records with the patient. Nurse will also review and set up the machine as necessary for the daily wellness parameters to be measured and entered by the patient. Data will be collected automatically for the length of the study (30 days). A 24-hr telephone number will be available to each patient to contact study nurse for any issues related to medication dispensing and/or health. Devices will be returned to the study investigator on Day 30 and the remaining pills in the pill dispenser will be manually counted by the study nurse in both groups for comparing against the automatically collected data.

Study identification

NCT ID
NCT07943663
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Not applicable
Lead sponsor
nucleusRx Inc
Industry
Enrollment
15 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 26, 2025 (Actual)
Primary completion
Dec 10, 2026 (Estimated)
Completion
Jan 15, 2027 (Estimated)
Last update posted
Nov 17, 2026

2025 – 2027

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
UH Portage Medical Center Ravenna Ohio 44266 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07943663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.